President’s Message

A message from Roy M. Fujitani, MD, FACS – Western Vascular Society President

Dear Colleagues,

It is my great pleasure to welcome you to the 39th Western Vascular Society Annual Meeting, where we gather to share knowledge, foster professional growth, and celebrate the achievements within our field. This year’s meeting at the Broadmoor in Colorado Springs from September 7-10, 2024 promises to be an enriching experience, centered around the vital theme of mentorship.

We are thrilled to welcome 20 medical student scholarship winners from around the country. These bright, aspiring surgeons represent the future of our field, and their presence at this meeting underscores the importance of the future of vascular surgery.

Mentorship has always been a cornerstone of our professional journey, shaping our careers, enhancing our skills, and guiding us to greater heights. As we come together for this event, we are reminded of the importance of nurturing the next generation of vascular surgeons and the impact of guidance and support in our community.

Roy M. Fujitani, MD, FACS

Professor of Surgery, Chief
Division of Vascular & Endovascular Surgery
Vice-Chair, Surgical Education
University of California
Irvine School of Medicine, Orange, CA

We are honored to have Dr. Todd Rasmussen as our Presidential guest lecturer. Dr. Rasmussen will deliver his keynote address on Sunday, September 8, 2024, titled “Leave no one behind: the odyssey to advance casualty care and improve wartime survival.” His extensive experience and groundbreaking contributions to casualty care and wartime survival will undoubtedly inspire and enlighten us all.

Additionally, we are excited to announce that the Diversity, Equity, and Inclusion (DEI) Committee is collaborating with the Vascular Surgery Interest Group to host a symposium focused on Coaching. This symposium will provide valuable insights into effective coaching strategies, enhancing our ability to mentor and support our peers and trainees.

Thanks to Dr. Jade Hiramoto the Program chair we have an exceptional program lined up, filled with powerful research sessions, engaging discussants, and ample opportunities for networking and collaboration. I encourage you to participate actively and take full advantage of the wealth of knowledge and expertise that will be shared.

Thank you for joining us in this celebration of mentorship and excellence in vascular surgery. Your presence and contributions are what make our society strong and vibrant. I look forward to seeing you all and sharing in this enriching experience.

Warmest regards,

Dr. Roy Fujitani, MD, FACS
President, Western Vascular Society

About Dr. Wei Zhou

Wei Zhou, MD, FACS, is a professor of surgery and the chief of the Division of Vascular and Endovascular Surgery at University of Arizona College of Medicine – Tucson. She is an internationally recognized expert in surgical and percutaneous management of vascular diseases involving the carotid, aorta, and lower extremities. She has extensive experience in carotid stenting, complex endovascular aneurysm repair, and minimally invasive treatment of lower extremity occlusive disease.

Prior to joining the University of Arizona, Dr. Zhou was on staff at Baylor College of Medicine in Texas and Stanford University in California, where she was a professor of surgery. Additionally, she was the chief of vascular surgery at the VA Palo Alto Heath Care System. During her tenure at Stanford, Dr. Zhou developed a state-of-the-art modern vascular surgery practice in Palo Alto VA. Under her leadership, Palo Alto VA provided and continues to provide advanced endovascular interventions and comprehensive care to patients with vascular diseases.

Dr. Zhou is a recognized surgeon-scientist and an NIH-funded physician investigator. Her research program focuses on clinical outcomes of vascular interventions and the mechanistic investigation of atherosclerotic disease. She has received funding from the NIH, the American Heart Association, the American College of Surgeons, and the Veteran Health Administration and is the principle investigator for more than 30 clinical trials. In addition, Dr. Zhou has authored or co-authored 120 peer-reviewed articles and 23 book chapters and has been invited to numerous national and international meetings for her thought leadership in the impacts of carotid interventions. She is fluent in both English and Chinese.